Form 4 Filing for Emergent BioSolutions Inc. - Joseph C. Papa

This filing details a Form 4 submission for Emergent BioSolutions Inc. (EBS), reporting on transactions by Joseph C. Papa, President and CEO. On April 29, 2026, Mr. Papa acquired 187,708 shares of Common Stock through restricted stock units granted under the company's Amended Stock Incentive Plan. This acquisition, valued at a transaction price of $0.0 per share, was approved by the Compensation Committee on March 2, 2026, and subsequently ratified by stockholders on April 29, 2026. The restricted stock units vest in three annual installments, contingent upon continued service. Following this transaction, Mr. Papa holds 493,153 shares of Common Stock. The filing also notes that the restricted stock unit grant was subject to stockholder approval of an amendment to the Company's 2006 Stock Incentive Plan, which was obtained on April 29, 2026. Each unit represents the right to one share of common stock, subject to adjustments as per the grant agreement.